leadforensics

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies. Find out more about cookies.

Click here to dismiss this banner

PHARMA REPORTS

rss_Pharma.jpg
Next>>
Global Wearable Medical Devices Market Forecast 2017-2027

Global Wearable Medical Devices Market Forecast 2017-2027

The global wearable medical devices market is expected to grow at a CAGR of 4.6% in the first half of the forecast period. In 2016, the wearable health & fitness devices submarket held 49% of the global wearable medical devices market.

...more details
Global Electronic Health Record Market 2017-2027

Global Electronic Health Record Market 2017-2027

The global electronic health record market is expected to grow at a CAGR of 5.6% from 2017 to 2027. In 2016, the Web-based EHR segment held 43% share of the global electronic health record market.

...more details
Smart Pill Market World Market Forecast 2017-2027

Smart Pill Market World Market Forecast 2017-2027

Our 133-page report provides 129 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Smart Pill market. See how to exploit the opportunities.

...more details
Global Bioreactors Market 2017-2027

Global Bioreactors Market 2017-2027

The global bioreactors market is expected to grow at a CAGR of 6.7% in the first half of the forecast period. In 2016, the full-scale production segment held the largest share in the global bioreactors market.

...more details
Rheumatoid Arthritis (RA) Drugs Market 2017-2027

Rheumatoid Arthritis (RA) Drugs Market 2017-2027

The introduction of new biologic drugs in Rheumatoid Arthritis, has led Visiongain to publish this timely report. The Rheumatoid Arthritis Drugs market is expected to flourish in the next few years because of rise to prominence of biosimilars that provides a way of reducing the cost of treatment for patients.

...more details
Neuromodulation Devices Report 2017-2027

Neuromodulation Devices Report 2017-2027

The revenue of the neuromodulation devices market in 2016 was estimated at $3.77bn and is expected to grow at a CAGR of 11.6% in the first half of the forecast period. The spinal cord stimulation segment accounted for the largest share of the market in 2016, this segment generated $1.89bn.

...more details
Global Smoking Cessation Drugs Market Forecast 2017-2027

Global Smoking Cessation Drugs Market Forecast 2017-2027

The global smoking cessation drugs market is expected to grow at a CAGR of 14.9% in the first half of the forecast period. In 2016, the non-nicotine pharmacotherapy submarket held 56.2% of the global smoking cessation drugs market.

...more details
Global Rehabilitation Equipment Market 2017-2027

Global Rehabilitation Equipment Market 2017-2027

The revenue of the rehabilitation equipment market in 2016 is estimated at $8.54bn and is expected to grow at a CAGR of 8.9% in the first half of the forecast period. Daily living aids accounted for the largest share of the market in 2016, this segment generated $3.42bn.

...more details
Checkpoint Inhibitors for Treating Cancer Market Report 2017-2027

Checkpoint Inhibitors for Treating Cancer Market Report 2017-2027

Where is the Checkpoint Inhibitors for Treating Cancer market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

...more details
Hepatitis C Therapies Market 2017-2027

Hepatitis C Therapies Market 2017-2027

The revenue of the Hepatitis C market in 2016 is estimated at $19bn and is expected to grow at a CAGR of 1.7% in the first half of the forecast period. Oral antivirals accounted for the largest share of the market in 2016, this segment generated $18.7bn.

...more details
Next>>

You have successfully subscribed. Thank you.

An internal error has occurred. Please try again later.

close